Multivariate Analysis Of Histopathological And Immunohistochemical Prognostic Factors In Endometrial Carcinoma. A Retrospective Pilot Study Of An Italian Regional Referral Center
Authors:
- Michele PaudiceMPMichele Paudice
- Giulia ScaglioneGSGiulia Scaglione
- Chiara Maria BiattaCBChiara Maria Biatta
- Fabio BarraFabio Barra
- Bruno SpinaBSBruno Spina
- Gabriele GaggeroGGGabriele Gaggero
- Ezio FulcheriEFEzio Fulcheri
- Simone FerreroSFSimone Ferrero
- Valerio Gaetano VelloneValerio Gaetano Vellone
- Gyn DmtGDGyn Dmt
Preprint
Abstract
Background: to investigate endometrial carcinoma prognostic value of some histopathological and immunohistochemical factors, fairly easily accessible in every routinely pathology lab set. Methods: we considered patients affected by endometrial carcinoma with available clinical and radiological follow-up data after radical hysterectomy (S. Martino Polyclinic Hospital, Genoa, Italy, period 1/1/2013 - 1/7/2016). We analyzed the following histopathological items: histotype, stage (FIGO), type of infiltration (infiltrative/espansive), desmoplasia, intratumoral necrosis, tumor infiltrating lymphocytes and lymph vascular spaces invasion. Moreover, each case has been investigated with a panel of immunohistochemistry including estrogen receptor α, progesteron receptor, Ki67, p53, β-catenin, e-cadherin, bcl-2 and cyclin D1. Primary endpoints were disease free survival and overall survival. Results: out of 99 cases eligible for our purpose, we found 69 low-grade endometrioid, 8 high-grade endometrioid and 22 other high-grade endometrial carcinomas. Disease free survival multivariate analysis showed a strong significant correlation between poor prognosis and advanced stage (p=0.0042). Advanced stage (p=0.0003) and presence of desmoplasia (p=0.04) resulted significantly correlated to a worse prognosis in overall survival multivariate analysis. In univariate model, the non-endometrioid histotype was significantly correlated with an unfavorable prognosis when compared to the endometriod type. Same for progesteron receptor low expression. Conclusion: the multivariate analysis confirmed the central prognostic role of stage in endometrial carcinoma. Moreover, other immunohistochemical markers in univariate analysis, have confirmed their easily reproducible usefulness, well integrating the recent TGCA molecular classification.Keywords
This publication has 37 references indexed in Scilit:
- CyclinD1, a prominent prognostic marker for endometrial diseasesDiagnostic Pathology, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical studyVirchows Archiv, 2010
- Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancerGynecologic Oncology, 2009
- Steroid receptor expressions in endometrial cancer: Clinical significance and epidemiological implicationCancer Letters, 2006
- Endometrial Cancer Incidence Trends in Europe: Underlying Determinants and Prospects for PreventionCancer Epidemiology, Biomarkers & Prevention, 2005
- Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid typeHistopathology, 2004
- Cyclin D1 gene (CCND1) mutations in endometrial cancerOncogene, 2003
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Lack of bcl-2 Persistence: An Independent Prognostic Indicator of Poor Prognosis in Endometrial CarcinomaGynecologic Oncology, 1998